New vice-chair appointed to Commission on Human Medicines

A new vice-chair has appointed to the Commission on Human Medicines (CHM); Dr Angela Thomas replaces Professor Ian Weller who retired from the position and from CHM on 31 December 2014. The CHM advises on matters relating to safety, quality and the efficacy of medicines as well as the collection of adverse drug reactions.

Dr Angela Thomas is a consultant paediatric haematologist at the Royal Hospital for Sick Children in Edinburgh, a fellow of the Royal College of Physicians in Edinburgh, a former President of the British Society for Haematology and has been on the CHM since 2005, where she chairs the Clinical Trials, Biologicals & Vaccines Expert Advisory Group. She has also served as a member and chaired many scientific and medical committees in the UK and Europe.

About the Medicines and Healthcare Products Regulatory Agency

The Medicines and Healthcare Products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are as safe as is reasonably possible. Underpinning all our work lies strong and evidence-based judgements to ensure that the benefits justify any risks. MHRA is a centre of the Medicines and Healthcare Products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research